G01N 2333/976
Trypsin
Official title: Trypsin; Chymotrypsin
G01N2333/976 (Trypsin) appears on 196 US grants and 177 published applications in this corpus.
Search patents in G01N- Granted patents
- 196
- Published applications
- 177
- Assignees
- 125
- Inventors
- 446
- Latest grant
- 14 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 0 | 0 |
| 1983 | 2 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 4 | 0 |
| 1996 | 7 | 0 |
| 1997 | 20 | 0 |
| 1998 | 26 | 0 |
| 1999 | 10 | 0 |
| 2000 | 7 | 0 |
| 2001 | 12 | 1 |
| 2002 | 6 | 12 |
| 2003 | 7 | 12 |
| 2004 | 4 | 10 |
| 2005 | 3 | 4 |
| 2006 | 5 | 8 |
| 2007 | 5 | 4 |
| 2008 | 4 | 6 |
| 2009 | 1 | 9 |
| 2010 | 2 | 7 |
| 2011 | 4 | 7 |
| 2012 | 7 | 7 |
| 2013 | 4 | 6 |
| 2014 | 5 | 3 |
| 2015 | 3 | 6 |
| 2016 | 5 | 10 |
| 2017 | 5 | 3 |
| 2018 | 5 | 3 |
| 2019 | 2 | 1 |
| 2020 | 4 | 5 |
| 2021 | 2 | 7 |
| 2022 | 0 | 4 |
| 2023 | 4 | 6 |
| 2024 | 1 | 15 |
| 2025 | 4 | 15 |
| 2026 | 2 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Hydrophobicity shifted enzyme14 Jul 2026US 12,681,019 B2Waters Technologies Corporation
- Systems and methods for assaying large molecules with improved sensitivity17 Feb 2026US 12,553,900 B2Genentech, Inc.
- Quantitative analysis of proteins6 May 2025US 12,292,448 B2Sigma-Aldrich Co.
- Composition comprising aflibercept and a variant thereof, and related methods and uses4 Mar 2025US 12,240,888 B1Qilu Pharmaceutical Co., Ltd.
- Methods for heat-assisted enzyme digestion21 Jan 2025US 12,202,857 B2Waters Technologies Corporation
- Tau assay8 Oct 2026US 2026/0309720 A1
- Peptide decorated nanoparticles for enrichment of specific protein subsets20 Aug 2026US 2026/0243777 A1Seer, Inc.
- Means and methods to determine cellular avidity9 Jul 2026US 2026/0194530 A1
- Method for diagnosing early and classifying stages of alzheimer's disease and determining amyloid beta accumulation in brain by using tau protein-derived phosphorylated peptide9 Jul 2026US 2026/0194539 A1Gwangju Institute of Science and Technology
- Size-based hierarchical extraction and identification method for microplastics in bivalves from deep-sea methane seeps5 Mar 2026US 2026/0063543 A1Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou)
Most cited
By later US patents
- Nucleic acid ligands561US 5,475,096 AUniversity Research Corporation · 1995
- Systematic evolution of ligands by exponential enrichment: Solution SELEX337US 5,567,588 AUniversity Research Corporation · 1996
- Systematic evolution of ligands by exponential enrichment: chimeric selex281US 5,637,459 ANeXstar Pharmaceuticals, Inc. · 1997
- High-affinity nucleic acid ligands that discriminate between theophylline and caffeine277US 5,580,737 ANeXstar Pharmaceuticals, Inc. · 1996
- Systematic evolution of ligands by exponential enrichment: blended SELEX233US 5,683,867 ANeXstar Pharmaceuticals, Inc. · 1997